tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RYTM is currently covered by 12 analysts with an average price target of $130.4. This is a potential upside of $20.12 (18.24%) from yesterday's end of day stock price of $110.28.
Rhythm Pharmaceuticals's activity chart (see below) currently has 132 price targets and 134 ratings on display. The stock rating distribution of RYTM is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 90.32% with an average time for these price targets to be met of 333.53 days.
Highest price target for RYTM is $142, Lowest price target is $65, average price target is $110.5.
Most recent stock forecast was given by CORINNE JENKINS from GOLDMAN SACHS on 16-Oct-2025. First documented stock forecast 29-Oct-2017.
Currently out of the existing stock ratings of RYTM, 45 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$139
$28.72 (26.04%)
$138
3 days ago
(16-Oct-2025)
9/11 (81.82%)
$28.72 (26.04%)
186
Buy
$110
$-0.28 (-0.25%)
$100
21 days ago
(28-Sep-2025)
12/12 (100%)
$9.36 (9.30%)
112
Buy
$142
$31.72 (28.76%)
$135
25 days ago
(24-Sep-2025)
3/5 (60%)
$42.86 (43.23%)
88
Buy
$122
$11.72 (10.63%)
$109
25 days ago
(24-Sep-2025)
11/13 (84.62%)
$22.86 (23.06%)
128
Buy
$120
$9.72 (8.81%)
$70
2 months 14 days ago
(05-Aug-2025)
1/2 (50%)
$29.99 (33.32%)
261
What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RYTM (Rhythm Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?
Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?
Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?
